Michael Brattain, PhD, professor at the Eppley Institute for Research in Cancer and associate director for basic research in the Fred and Pamela Buffett Cancer Center at the University of Nebraska in Omaha, died March 5, 2016, at the age of 68.
Brattain had been a member of the AACR since 1977, having served as an associate editor of Cancer Research and a mentor in grant writing workshops for the Associate Member Council.
Brattain’s research focused on the mechanisms for metastasis in colon cancer in order to find new treatment targets. He had been continuously funded by the National Cancer Institute (NCI) since the first grant he received in 1978, including a MERIT award in 2007.
After receiving his doctorate from Rutgers University in New Brunswick, New Jersey, Brattain began his research career at the University of Alabama, Birmingham. Prior to his arrival at the University of Nebraska in 2007, Brattain held faculty positions at Baylor College of Medicine in Houston, Medical College of Ohio in Toledo, University of Texas Health Science Center, San Antonio Cancer Institute, and Roswell Park Cancer Institute in Buffalo, New York.
Brattain was recognized with the University of Nebraska Medical Center’s Distinguished Scientist Award in 2009, Outstanding Mentor of Graduate Students Award in 2011, and the Research Leadership Award in 2015.